A phase I/II study of sunitinib and dacarbazine in patients with metastatic melanoma.
Latest Information Update: 05 Mar 2011
At a glance
- Drugs Sunitinib (Primary) ; Dacarbazine
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2011 Planned end date changed from 1 Jun 2008 to 1 Jun 2007 as reported by ClinicalTrials.gov.
- 28 Jan 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov, last updated 28 Jan 2009.
- 28 Jan 2009 Planned patient numbers (11) added as reported by ClinicalTrials.gov.